Trial Profile
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Oct 2021 Planned End Date changed from 1 Dec 2015 to 1 May 2015.
- 04 Oct 2021 Planned primary completion date changed from 1 Oct 2015 to 1 May 2015.
- 04 Oct 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.